Interphex Insider: The Future-Ready Biomanufacturing Facility
Meg Carr reflects on the key themes from this year’s show – from contamination control and AI to flexible facility design
False
Meg Carr reflects on the key themes from this year’s show – from contamination control and AI to flexible facility design
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han
August 31, 2026
4 min read
New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products
August 28, 2026
2 min read
Christine Allen believes AI will connect every stage of drug development, but only if it remains guided by human expertise
August 27, 2026
9 min read
Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong
False
Affiliations:
Specialties:
Areas of Expertise: